Securing and utilizing the patent portfolio
First written in FY2016. 24 of 37 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
2 other companies' latest entry also says "Other".
- FY2026Decrease in the number of patents obtainedAnnual report
「As of 31 March 2026, the Company held 455 patents worldwide. The number of patents varies from time to time due to reviews of its intellectual property strategy, including defensive patents, and the status of procedures in each country following the use of PCT international applications.」
The number of patents held worldwide decreased from 485 at the end of the previous period to 455. The company continues to explain that the number fluctuates due to reviews of its intellectual property strategy and procedures in each country. - FY2026-H1Decrease in the number of patents obtainedAnnual report
「As of 30 September 2025, the company held 472 patents worldwide. The number of patents fluctuates from time to time due to reviews of the company's intellectual property strategy, including defensive patents, and the status of procedures in each country following the use of PCT international applications, among other factors.」
The number of patents held worldwide decreased from 485 at the end of the previous period to 472. The company continues to explain that the number fluctuates due to reviews of its intellectual property strategy and procedures in each country. - FY2025AdvancedAnnual report
「As of 31 March 2025, the company held 485 patents worldwide.」
The number of patents held worldwide increased from 312 as of 30 September 2024, as stated in FY2025-H1, to 485. The company explains that the number of patents fluctuates from time to time due to reviews of its intellectual property strategy and the status of procedures in each country following PCT international applications, among other factors. - FY2025-H1Decrease in the number of patents obtainedAnnual report
「As of 30 September 2024, the company held 312 patents worldwide. The number of patents fluctuates from time to time due to reviews of the company's intellectual property strategy, including defensive patents, and the status of procedures in each country following the use of PCT international applications, among other factors.」
The number of patents held worldwide decreased from 317 in FY2024 to 312. The company explains that the number of patents fluctuates due to reviews of its intellectual property strategy and the status of procedures in each country following PCT international applications, among other factors. - FY2024AdvancedAnnual report
「As of 31 March 2024, the company held 317 patents worldwide.」
The number of patents held worldwide increased from 297 as of 31 December 2023, as previously stated, to 317. - FY2024-Q3AdvancedAnnual report
「As of 31 December 2023, the company held 297 patents worldwide. The number of patents fluctuates from time to time due to reviews of the company's intellectual property strategy, including defensive patents, and the status of procedures in each country following the use of PCT international applications, among other factors.」
The number of patents held worldwide increased from 293 as of 30 September 2023, as previously stated, to 297. The explanation that the number of patents fluctuates due to reviews of the intellectual property strategy and procedures in each country also continues. - FY2024-Q2Decrease in the number of patents obtainedAnnual report
「As of 30 September 2023, the company held 293 patents worldwide. The number of patents fluctuates from time to time due to reviews of the company's intellectual property strategy, including defensive patents, and the status of procedures in each country following the use of PCT international applications, among other factors.」
The number of patents held worldwide decreased from 466 in FY2024-Q1 to 293. The company explains that the number fluctuates due to reviews of its intellectual property strategy, including defensive patents, and the status of procedures in each country following PCT international applications, among other factors. - FY2024-Q1AdvancedAnnual report
「As of 30 June 2023, the company held 466 patents worldwide.」
The number of patents held worldwide increased from 355 as of 31 March 2023 to 466. The company explains that the number of patents fluctuates from time to time due to reviews of its intellectual property strategy and the status of procedures in each country following PCT international applications, among other factors. - FY2023Decrease in the number of patents obtainedAnnual report
「As of 31 March 2023, the company held 355 patents worldwide.」
The number of patents held worldwide decreased from the 457 stated as of 31 December 2022 to 355. This document explains that the number fluctuates due to reviews of the intellectual property strategy, including defensive patents, and the status of procedures in each country following PCT international applications, among other factors. - FY2023-Q3AdvancedAnnual report
「As of 31 December 2022, the company held 457 patents worldwide.」
The number of patents held worldwide increased from the previously stated 450 to 457. - FY2023-Q2Decrease in the number of patents obtainedAnnual report
「As of 30 September 2022, the company held 450 patents worldwide.」
The number of patents held worldwide decreased from 528 as of 30 June 2022, as previously stated, to 450. This document does not explain the reason for the decrease. - FY2023-Q1Decrease in the number of patents obtainedAnnual report
「As of 30 June 2022, the company held 528 patents worldwide.」
The number of patents held worldwide decreased from 631 as of 31 March 2022 to 528. This document does not explain the reason for the decrease. - FY2022AdvancedAnnual report
「As of 31 March 2022, the company held 631 patents worldwide.」
The number of patents held worldwide increased from the previously stated 615 to 631. - FY2022-Q3AdvancedAnnual report
「As of 31 December 2021, the company held 615 patents worldwide.」
The number of patents held worldwide increased from the previously stated 604 to 615. - FY2022-Q2AdvancedAnnual report
「As of 30 September 2021, the company held 604 patents worldwide.」
The number of patents held worldwide increased from the previously stated 587 to 604. - FY2022-Q1AdvancedAnnual report
「As of 30 June 2021, the company held 587 patents worldwide.」
The number of patents held worldwide increased from the previously stated 557 to 587. - FY2021-Q3AdvancedAnnual report
「As of 31 December 2020, the company held 557 patents worldwide.」
The number of patents held worldwide increased from the previously stated 543 to 557. - FY2021-Q2AdvancedAnnual report
「As of 30 September 2020, the company held 543 patents worldwide.」
The number of patents held worldwide increased from the previously stated 532 to 543. - FY2021-Q1AdvancedAnnual report
「As of 30 June 2020, the company held 532 patents worldwide.」
The number of patents held worldwide increased from 522 at the end of the previous consolidated fiscal year to 532. - FY2020AdvancedAnnual report
「As of 31 March 2020, the company held 522 patents worldwide.」
The number of patents held worldwide increased from the previously stated 512 to 522. - FY2020-Q3AdvancedAnnual report
「As of 31 December 2019, the company held 512 patents worldwide.」
The number of patents held worldwide increased from the previously stated 501 to 512. - FY2020-Q2Fewer patents statedAnnual report
「As of 30 September 2019, the company held 501 patents worldwide.」
The number of patents held worldwide decreased from the previously stated 522 to 501. This document does not explain the reason for the decrease. - FY2020-Q1Fewer patents statedAnnual report
「As of 30 June 2019, the company held 522 patents worldwide.」
The number of patents held worldwide decreased from the previously stated 529 to 522. This document does not explain the reason for the decrease. - FY2019-Q3AdvancedAnnual report
「As of 31 December 2018, the company held 529 patents worldwide.」
The number of patents held worldwide increased from the previously stated 507 to 529. - FY2019-Q2AdvancedAnnual report
「As of 30 September 2018, the company held 507 patents worldwide.」
The number of patents held worldwide increased from the previously stated 488 to 507. - FY2019-Q1AdvancedAnnual report
「As of 30 June 2018, the company held 488 patents worldwide.」
The number of patents held worldwide increased from the previously stated 480 to 488. - FY2018AdvancedAnnual report
「As of 31 March 2018, the company held 480 patents worldwide.」
The number of patents held worldwide increased from the previously stated 459 to 480. - FY2018-Q3AdvancedAnnual report
「As of 31 December 2017, the company held 459 patents worldwide.」
The number of patents held worldwide increased from the previously stated 442 to 459. - FY2018-Q2Fewer patents statedAnnual report
「As of 30 September 2017, the company held 442 patents worldwide.」
The company stated that it held 442 patents. Although the stated figure decreased from the 466 reported for FY2018-Q1 immediately prior, this document does not explain why. - FY2018-Q1AdvancedAnnual report
「As of 30 June 2017, the company held 466 patents worldwide.」
The number of patents held worldwide increased from the previously stated 442 to 466. - FY2017AdvancedAnnual report
「As of 31 March 2017, the company held 442 patents worldwide.」
The number of patents held worldwide increased from the previous 415 to 442. - FY2017-Q3AdvancedAnnual report
「As of 31 December 2016, the company held 415 patents worldwide.」
The number of patents held worldwide increased from the previous 404 to 415. - FY2017-Q2AdvancedAnnual report
「As of 30 September 2016, the company held 404 patents worldwide.」
The number of patents held worldwide increased from the 381 stated previously to 404. - FY2017-Q1AdvancedAnnual report
「As of 30 June 2016, the company held 381 patents worldwide.」
The number of patents held worldwide was stated as 381, up from the 365 stated previously. - FY2016First statedAnnual report
「As of the end of March 2016, the company had filed 1,527 patent applications worldwide covering information on cancer-related genes and gene products discovered through joint research with the University of Tokyo and other universities, drug candidate compounds, and other such items, as well as drug candidate compounds and other such items discovered independently by the company.」
The company also states that it holds 365 patents worldwide. Its policy is to secure rights through comprehensive assignment agreements and other arrangements with universities.